Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Meredith McKean, MD, MPH
Tennessee Oncology
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Health Network, Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Institut Bergonie
Bordeaux, France
- Centre Leon Berard
Lyon, France
- Institut Paoli-Calmettes
Marseille, France
- Centre Eugene Marquis
Rennes, France
- Institut Gustave Roussy
Villejuif, France
- Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, MI, Italy
- Ospedale San Raffaele
Milan, Italy
- Hospital Clinic de Barcelona
Barcelona, Spain
- Vall D'Hebron Institute of Oncology
Barcelona, Spain
- Start Madrid Fundacion Jimenez Diaz
Madrid, Spain
- Next Oncology - Hospital Quironsalud Madrid
Pozuelo de Alarcón, Spain
- Hospital Universitario Marques de Valdecilla
Santander, Spain
- Sarah Cannon Research Institute Uk
London, United Kingdom
- the Christie Nhs Foundation Trust
Manchester, United Kingdom
- Sarah Cannon Research Institute at Healthone
Denver, Colorado, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Advent Health
Orlando, Florida, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Thomas Jefferson University, Sidney Kimmel Cancer Center
Philadelphia, Pennsylvania, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
- Mary Crowley Cancer Research Center
Dallas, Texas, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Jul 2020
- Primary completion
- 31 Mar 2026
- Completion
- 31 Dec 2026
- Last update posted
- 14 Nov 2025
- Registered enrollment
- 329
- Registry id
- NCT04561362
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.